Document is current
Any future updates will be listed below
-
Authors
Viozzi, Ilaria
Overduin, Christiaan G.
Rijpma, Anne
Rovers, Maroeska M.
Laan, Mark ter
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04596930 at ClinicalTrials.govDocuments that mention this clinical trial
MR-guided LITT therapy in patients with primary irresectable glioblastoma: a prospective, controlled pilot study
https://doi.org/10.1007/s11060-023-04371-x
-
Funding
Funding for this research was provided by:
Medtronic Europe (Grant ERP-2020-12244)
Medtronic Europe (Grant ERP-2020-12244)
Medtronic Europe (Grant ERP-2020-12244)
- License Information
-
More Information
Article History
Received: 18 May 2023
Accepted: 10 June 2023
First Online: 28 July 2023
Declarations
:
: Currently all authors are involved in a government funded RCT on laser ablation in glioblastoma (NCT05318612).
: The study was performed in line with the principles of the Declaration of Helsinki and was approved by the Institutional Review Board (METC Oost Nederland).
: Written informed consent was obtained from all participants before enrolment.
